Skip to main content
Clinical Trials/IRCT20081208001497N10
IRCT20081208001497N10
Recruiting
Phase 3

Evaluation of the effect of licorice as an adjunct treatment for patients with Covid-19 admitted to the intensive care unit: A randomized, placebo-controlled, double-blind clinical trial

Esfahan University of Medical Sciences0 sites60 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Covid-19.
Sponsor
Esfahan University of Medical Sciences
Enrollment
60
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Covid\-19 diagnosis based on PCR test
  • Hospitalized in the intensive care unit and under mechanical ventilation

Exclusion Criteria

  • 1\. Patients with high blood pressure (\<90/140\)
  • Patients with congestive heart failure
  • Patients with severe liver, kidney and thyroid disease
  • Concomitant use of warfarin, SSRI, MAOI, diuretics, antiarrhythmic drugs
  • Treatment with antiviral drugs one month before entering the study
  • Allergy to licorice
  • Pregnancy and lactation
  • Dissatisfaction of the patient or his legal guardian
  • Infected with Covid\-19 for at least 20 days prior to enrollment

Outcomes

Primary Outcomes

Not specified

Similar Trials